Agennix AG | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
EUR2.05 M |
Shares Outstanding |
51.27 M |
Public Float |
- |
Address |
Im Neuenheimer Feld 515 Heidelberg Baden Wuerttemberg 69120 Germany |
Employees | - |
Website | http://www.agennix.com |
Updated | 09/14/2018 |
Agennix AG is a biopharmaceutical company, which engages in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs include oral talactoferrin alfa and RGB-286638. The company was founded on November 5, 2009 and is headquartered in Heidelberg, Germany. |